Skip to main content

Audenz Seqirus Pty Ltd

Product name
Audenz
Sponsor
Accepted date
May-2024
Active ingredients
Influenza virus haemagglutinin
Proposed indication
Prophylaxis of influenza in an officially declared pandemic situation in persons aged 6 months of age and older.
Application type
A (new medicine)
Publication date
May-2024

Help us improve the Therapeutic Goods Administration site